Liu, Sophia Z.
Marcinek, David J.
Funding for this research was provided by:
National Institute on Aging (AG001751, AG000057)
American Federation for Aging Research (Breakthrough in Gerontology)
Article History
First Online: 5 November 2016
Compliance with ethical standards
:
: David Marcinek serves as a paid consultant to Stealth BioTherapeutics. Stealth is developing the compound elamipretide (SS-31) for clinical use. Sophia Liu has no conflict of interest to report.